Evidence map›Paper›PMID 41355915›Full record

ArticleWorld journal of clinical oncology2025

Role of endoscopic ultrasonography or magnetic resonance imaging for screening of pancreatic cancer in low-risk individuals.

Wei-Chen Lin, Lo-Yip Yu, Yang-Che Kuo, Chen-Wang Chang, Horng-Yuan Wang, Shou-Chuan Shih, Ching-Wei Chang, Hsiang-Hung Lin, Yi-Hsueh Chan, Ying-Chun Lin and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wei-Chen LinDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei 104217, Taiwan.
Lo-Yip YuDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei 104217, Taiwan.
Yang-Che KuoDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei 104217, Taiwan.
Chen-Wang ChangDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei 104217, Taiwan.
Horng-Yuan WangDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei 104217, Taiwan.
Shou-Chuan ShihDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei 104217, Taiwan.
Ching-Wei ChangDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei 104217, Taiwan.
Hsiang-Hung LinDianthus Internal Medicine Clinic Minquan, Dianthus Medical Group, Taipei 114067, Taiwan.
Yi-Hsueh ChanDianthus Internal Medicine Clinic Minquan, Dianthus Medical Group, Taipei 114067, Taiwan.
Ying-Chun LinDepartment of Anesthesia, MacKay Memorial Hospital, Taipei 104217, Taiwan.
Kuang-Chun HuDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei 104217, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMagnetic resonance imaging (MRI) and endoscopic ultrasonography (EUS) are recommended in combination for screening pancreatic cancer in high-risk individuals. However, in clinical practice, MRI and EUS are increasingly utilized for pancreatic surveillance during routine health examinations.

aimTo investigate the feasibility of these imaging modalities for screening in low-risk individuals.

methodsThis retrospective study included patients at low risk for pancreatic cancer who underwent MRI or EUS at two health evaluation centers between March 2019 and December 2024. Basic characteristics, laboratory data, and imaging results were collected.

resultsA total of 3364 low-risk individuals underwent pancreatic screening: 1553 (46.1%) received MRI, and 1811 underwent EUS. No significant differences were observed in age or sex distribution between the groups. In imaging screening, EUS demonstrated a higher detection rate of abnormal pancreatic lesions (12.8%

conclusionIn low-risk individuals, MRI and EUS offer comparable effectiveness for pancreatic cancer surveillance. The choice of imaging strategy for health evaluation depends on cost considerations and degree of invasiveness.

Indexed as

Endoscopic ultrasonographyLow-risk individualsMagnetic resonance imagingPancreatic cancerScreening

Identifiers

PMID41355915
PMCPMC12678969

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.